Day One Biopharmaceuticals, Inc. Quarterly Nonoperating Income (Expense) in USD from Q2 2023 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Day One Biopharmaceuticals, Inc. annual/quarterly Nonoperating Income (Expense) history and growth rate from Q2 2023 to Q3 2024.
  • Day One Biopharmaceuticals, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $6.52M, a 23.3% increase year-over-year.
  • Day One Biopharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2024 was $129M, a 652% increase from 2023.
  • Day One Biopharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2023 was $17.1M, a 263% increase from 2022.
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $6.52M +$1.23M +23.3% Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-30
Q2 2024 $112M +$109M +3201% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-02
Q3 2023 $5.29M Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-30
Q2 2023 $3.39M Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.